Cerenome, Inc. (CNSY)
2.25
-0.08
(-3.23%)
USD |
NASDAQ |
Sep 14, 10:51
Cerenome Total Assets (Quarterly) : 14.03M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.03M |
| March 31, 2026 | 19.92M |
| December 31, 2025 | 16.32M |
| September 30, 2025 | 18.67M |
| June 30, 2025 | 10.35M |
| March 31, 2025 | 12.06M |
| December 31, 2024 | 6.633M |
| September 30, 2024 | 6.978M |
| June 30, 2024 | 11.21M |
| March 31, 2024 | 5.621M |
| December 31, 2023 | 11.39M |
| September 30, 2023 | 13.28M |
| June 30, 2023 | 14.20M |
| March 31, 2023 | 15.64M |
| December 31, 2022 | 23.87M |
| September 30, 2022 | 23.10M |
| June 30, 2022 | 21.27M |
| March 31, 2022 | 24.52M |
| December 31, 2021 | 21.98M |
| September 30, 2021 | 24.75M |
| June 30, 2021 | 20.83M |
| March 31, 2021 | 18.34M |
| December 31, 2020 | 12.10M |
| September 30, 2020 | 11.65M |
| June 30, 2020 | 13.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.97M |
| December 31, 2019 | 23.23M |
| September 30, 2019 | 25.72M |
| June 30, 2019 | 8.884M |
| March 31, 2019 | 24.62M |
| December 31, 2018 | 23.99M |
| September 30, 2018 | 25.53M |
| June 30, 2018 | 22.68M |
| March 31, 2018 | 26.64M |
| December 31, 2017 | 31.62M |
| September 30, 2017 | 26.45M |
| June 30, 2017 | 32.48M |
| March 31, 2017 | 29.77M |
| December 31, 2016 | 34.61M |
| September 30, 2016 | 36.84M |
| June 30, 2016 | 42.68M |
| March 31, 2016 | 32.92M |
| December 31, 2015 | 37.70M |
| September 30, 2015 | 42.45M |
| June 30, 2015 | 46.52M |
| March 31, 2015 | 37.05M |
| December 31, 2014 | 38.72M |
| September 30, 2014 | 32.31M |
| June 30, 2014 | 38.25M |
| March 31, 2014 | 39.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ernexa Therapeutics, Inc. | 6.315M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 8.567M |
| Shareholders Equity (Quarterly) | 5.463M |
| Debt to Equity Ratio | 0.0081 |
| Current Ratio | 1.346 |
| Net Debt Paydown Yield | 0.00% |